CDKN2B-AS1 and gastric cancer: For example, a study reported that silencing ANRIL could hinder the development of MDR in gastric cancer cells [13], which could also up-regulate microRNA let-7a to inhibit tumorigenicity and enhance the chemosensitivity of nasopharyngeal carcinoma cells to cisplatin [14].